|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Free Homocysteine (HCY) ELISA | Amyloid Beta (1-42) ELISA Assay | Amyloid Beta (1-x) ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Soluble Leptin Receptor (sLEP-R) ELISA |
| Citations | | | | | |
| Catalog Number | IB08058 | 27711 | 27729 | 27600 | R07 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay for detection of Free Homocysteine (HCY) concentrations in serum, plasma, cell culture supernatant and other biological samples. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß (1-x) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Enzyme immunoassay (ELISA) for the determination of soluble human leptin receptor (sLEP-R) in human serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Free Homocysteine (HCY) ELISA | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | BACE1 | Metanephrine / Normetanephrine | Parvovirus B19 IgG |
| Sample Type | Serum, plasma, cell culture supernatant, and other biological samples. | Serum and plasma. | Brain Extracts, Cultured Cell Lysate | Urine | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.25 - 16 umol/L | 12.5 to 800 pg/mL | 7.81 to 500 pg/mL | 1.56 to 100.0 ng/mL | 0 / 3.125 – 150 ng/mL |
| Sensitivity | 0.15 umol/L | 1 ng/mL | 0.16 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 98% |
| Assay Time | 45 min. incubation (37°C) + 30 min. (37°C) + 10-20 min. (37°C) = 1 hour, 35min. total incubation time. | Overnight + 1 hr 30 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hours (incubation) | 5 hour total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |